OFIRMEV Drug Patent Profile

When do Ofirmev patents expire, and what generic alternatives are available?

Ofirmev is a drug marketed by Mallinckrodt Hosp and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge.

This drug has four patent family members in three countries.

The generic ingredient in OFIRMEV is acetaminophen. There are sixty-six drug master file entries for this compound. Ninety suppliers are listed for this compound. Additional details are available on the acetaminophen profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Ofirmev

A generic version of OFIRMEV was approved as acetaminophen by PERRIGO on February 25^th, 2000.

Summary for OFIRMEV

International Patents:	4
US Patents:	4
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	179
Clinical Trials:	60
Patent Applications:	5,828
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for OFIRMEV
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for OFIRMEV
What excipients (inactive ingredients) are in OFIRMEV?	OFIRMEV excipients list
DailyMed Link:	OFIRMEV at DailyMed

See drug prices for OFIRMEV

Recent Clinical Trials for OFIRMEV

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Beth Israel Deaconess Medical Center	Phase 3
National Institute on Aging (NIA)	Phase 3
Lotus Clinical Research, LLC	Phase 2

See all OFIRMEV clinical trials

Paragraph IV (Patent) Challenges for OFIRMEV

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
OFIRMEV	Injection	acetaminophen	1000 mg/100 mL (10 mg/mL)	022450	1	2011-04-07

US Patents and Regulatory Information for OFIRMEV

OFIRMEV is protected by five US patents.

Patents protecting OFIRMEV

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mallinckrodt Hosp	OFIRMEV	acetaminophen	SOLUTION;INTRAVENOUS	022450-001	Nov 2, 2010		DISCN	Yes	No
Mallinckrodt Hosp	OFIRMEV	acetaminophen	SOLUTION;INTRAVENOUS	022450-001	Nov 2, 2010		DISCN	Yes	No					Y
Mallinckrodt Hosp	OFIRMEV	acetaminophen	SOLUTION;INTRAVENOUS	022450-001	Nov 2, 2010		DISCN	Yes	No					Y

Expired US Patents for OFIRMEV

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Mallinckrodt Hosp	OFIRMEV	acetaminophen	SOLUTION;INTRAVENOUS	022450-001	Nov 2, 2010
Mallinckrodt Hosp	OFIRMEV	acetaminophen	SOLUTION;INTRAVENOUS	022450-001	Nov 2, 2010

International Patents for OFIRMEV

See the table below for patents covering OFIRMEV around the world.

Country	Patent Number	Title	Estimated Expiration
Canada	2233924	NOUVELLES FORMULATIONS LIQUIDES STABLES A BASE DE PARACETAMOL ET LEUR MODE DE PREPARATION (NOVEL STABLE LIQUID PARACETAMOL COMPOSITIONS, AND METHOD FOR PREPARING SAME)
France	2809619	NOUVELLES FORMULATIONS AQUEUSES DE PRINCIPES ACTIFS SENSIBLES A L'OXYDATION ET LEUR PROCEDE D'OBTENTION
Mexico	9802734	NUEVAS FORMULACIONES LIQUIDAS ESTABLES A BASE DE PARACETAMOL Y SU MODO DE PREPARACION. (NOVEL STABLE LIQUID PARACETAMOL COMPOSITIONS, AND METHOD FOR PREPARING SAME.)